Search
forResearch 10 of 1000+
- Telogen Effluvium due to Recombinant Interferon α-2b
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- Dermatologic therapy: December 1986 to December 1987
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Interferon alpha 2B
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- Failure to induce alopecia areata in C3H/HeJ mice with exogenous interferon gamma
- CUTANEOUS T-CELL LYMPHOMA
- Interferon in the treatment of cutaneous T-cell lymphoma
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →